Recombinant human prourokinase is noninferior to alteplase and associated with decreased bleeding risks among patients with acute ischemic stroke, a new trial showed.

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication associated with bone marrow transplant, as well as a novel HIV drug that only ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Researchers developed a novel calculator may help to tailor pain medication regimens to patients with SCD seeking emergency ...

Eunice S. Wang, MD, discusses a retrospective study of 105 patients diagnosed with secondary acute myeloid leukemia.

The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...

New research is highlighting the use of ozone therapy and its potential to help treat acute lung injuries caused by sepsis.

Sepsis, a severe and often fatal complication of infection, is a leading cause of both ALI and acute respiratory distress ...

The results suggest that streptokinase therapy is practicable provided that adequate laboratory control is available, and that it hastens early resolution in acute major pulmonary embolism.

Tyler Perry reminds us that starting therapy is never too late. The director was recently a guest on The View and revealed that he began therapy for the first time at 54. Perry said a question ...

Dec. 18, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy ...